Lars Granlöf appointed Vice President, Corporate Control

Lars Granlöf appointed Vice President, Corporate Control Lars Granlöf has today been appointed acting Vice President, Corporate Control of Gambro. He is presently Vice President, Finance, a responsibility he will keep. Granlöf will be a co-opted member of the Gambro Executive Committee. He is succeeding Sören Mellstig, who has taken over the responsibility for the business area Renal Care Products. For further information please contact: Bengt Modéer, Senior Vice President, Corporate Communications, tel. +46-8-613 65 00, +46-70-513 65 33 Anna Augustson, European Investor Relations Manager, tel. +46-8-613 65 35, +46-70-513 65 34 Tim Schoenberg, Vice President, Communications, US, tel. +1-303-232-6800 Gambro is a global healthcare company with leading positions in renal care - services and products - and blood component technology (BCT). Gambro is the second largest provider of kidney dialysis services in the world. Gambro treats about 40,000 patients in 460 clinics worldwide. Renal care products comprise dialyzers, dialysis machines, blood lines and dialysis fluid. BCT includes products for the separation and handling of blood components. The Group, with revenue of approximately SEK 18 billion (USD 2.3 billion) has 17,000 employees in some 40 countries. ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/1999/01/22/19990122BIT00240/bit0001.doc http://www.bit.se/bitonline/1999/01/22/19990122BIT00240/bit0002.pdf

About Us

Gambro is a global medical technology and healthcare company with leading positions in renal care - services and products - and blood component technology. The group, with revenue of approximately SEK 18 billion (USD 2.2 billion), has approximately 17,000 employees in some 40 countries.

Subscribe